日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Association Between Transfusion Status, Hemoglobin Levels, and Patient-Reported Outcomes in Myelofibrosis: A Post Hoc Clinical Trial Analysis

输血状况、血红蛋白水平与骨髓纤维化患者报告结局之间的关联:一项事后临床试验分析

Mesa, Ruben; Palmer, Jeanne M; Palandri, Francesca; Masarova, Lucia; Harrison, Claire N; Mazerolle, Flora; M'hari, Manal; Liu, Tom; Zhang, Shiyuan; Cardellino, Anna; Wang, Zhaohui; Ellis, Catherine E; Patnaik, Dwaipayan; Regnault, Antoine; LeBlanc, Thomas W

Preclinical efficacy of CDK7 inhibitor-based combinations against myeloproliferative neoplasms transformed to AML.

CDK7抑制剂联合疗法对转化为AML的骨髓增生性肿瘤的临床前疗效

Fiskus Warren, Mill Christopher P, Bose Prithviraj, Masarova Lucia, Pemmaraju Naveen, Dunbar Andrew, Birdwell Christine E, Davis John A, Das Kaberi, Hou Hanxi, Manshouri Taghi, Jain Antrix, Malovannaya Anna, Philip Kevin, Alhamadani Noor, Matthews Alicia, Lin Katie, Flores Lauren B, Loghavi Sanam, DiNardo Courtney, Su Xiaoping, Rampal Raajit K, Bhalla Kapil N

A Phase 2 study of CPX-351 in combination with venetoclax in patients with newly diagnosed high-risk acute myeloid leukemia

一项针对新诊断的高危急性髓系白血病患者的 CPX-351 联合维奈托克治疗的 II 期研究

Jen, Wei-Ying; Croden, Jennifer; Almanza-Huante, Emmanuel; DiNardo, Courtney; Chien, Kelly; Hammond, Danielle; Qiao, Wei; Alvarado, Yesid; Masarova, Lucia; Quesada, Andres E; Pierce, Sherry; Bataller, Alex; Garcia-Manero, Guillermo; Alousi, Amin; Short, Nicholas; Daver, Naval; Ravandi, Farhad; Kantarjian, Hagop; Kadia, Tapan M

VEN in combination with 10-day DEC in newly diagnosed elderly or relapsed/refractory acute myeloid leukemia, and high-risk myelodysplastic syndrome: long term follow-up of a phase 2 trial

VEN联合10天DEC治疗新诊断的老年或复发/难治性急性髓系白血病和高危骨髓增生异常综合征:一项II期试验的长期随访

Swaminathan, Mahesh; DiNardo, Courtney D; Maiti, Abhishek; Pemmaraju, Naveen; Ohanian, Maro; Daver, Navel G; Garcia-Manero, Guillermo; Issa, Ghayas C; Borthakur, Gautam; Ravandi, Farhad; Montalban-Bravo, Guillermo; Kadia, Tapan M; Alvarado, Yesid; Jabbour, Elias J; Short, Nicholas J; Wierda, William G; Jain, Nitin; Kornblau, Steven M; Masarova, Lucia; Pierce, Sherry A; Qiao, Wei; Ning, Jing; Kantarjian, Hagop; Konopleva, Marina Y

A phase I/IIa trial of PXS-5505, a novel pan-lysyl oxidase inhibitor, in advanced myelofibrosis

一项针对晚期骨髓纤维化的新型泛赖氨酰氧化酶抑制剂 PXS-5505 的 I/IIa 期试验

Vachhani, Pankit; Tan, Peter; Watson, Anne-Marie; Wu, Shang-Ju; Baker, Ross; Cheung, Stanley; Lee, Sung-Eun; Chen, Chih-Cheng; Chen, Tsai-Yun; Hsiao, Hui-Hua; Lee, Jae Hoon; Masarova, Lucia; Tan, Shuh Ying; Baskar, Jana; Charlton, Brett; Findlay, Alison; Hamprecht, Dieter; Jarolimek, Wolfgang; Leadbetter, Joanna; Miller, John; Morgan, Kristen; Zahoor, Amna; Hobbs, Gabriela

A phase II trial of azacitidine with ipilimumab, nivolumab, or ipilimumab and nivolumab in previously untreated myelodysplastic syndrome

一项针对既往未接受治疗的骨髓增生异常综合征患者的阿扎胞苷联合伊匹木单抗、纳武利尤单抗或伊匹木单抗联合纳武利尤单抗的II期临床试验

Bouligny, Ian M; Montalban-Bravo, Guillermo; Sasaki, Koji; Daver, Naval; Jabbour, Elias; Alvarado, Yesid; DiNardo, Courtney D; Ravandi, Farhad; Borthakur, Gautam; Bose, Prithviraj; Pemmaraju, Naveen; Kornblau, Steven; Kadia, Tapan; Masarova, Lucia; Takahashi, Koichi; Andreeff, Michael; Bazinet, Alexandre; Yang, Hui; Kanagal-Shamanna, Rashmi; Hosing, Chitra; Pierce, Sherry; Meyer, Meghan; Huang, Xuelin; Garcia-Manero, Guillermo

A multicenter study to assess efficacy, safety, and tolerability of ropeginterferon alfa-2b-njft in patients with essential thrombocythemia in the US and Canada: EXCEED-ET trial

一项在美国和加拿大开展的多中心研究旨在评估罗培干扰素α-2b-njft治疗原发性血小板增多症患者的疗效、安全性和耐受性:EXCEED-ET试验

Masarova, Lucia; Reeves, Brandi N; El Chaer, Firas; Foltz, Lynda; Tashi, Tsewang; Abu-Zeinah, Ghaith; Lucas, Jennifer; Halpern, Anna B; Maze, Dawn; Qin, Albert; Safah, Hana; Lan, Fengshuo; O'Connell, Casey L; Goel, Swati; Rein, Lindsay; Fang, Bruno; How, Joan; Babu, Sunil; Li, Zhuoyan; Cerquozzi, Sonia; Oh, Stephen T; Hunter, Anthony M; Podoltsev, Nikolai; Vachhani, Pankit; Yacoub, Abdulraheem; Cunningham, Julia M; Hillis, Christopher; Otoukesh, Salman; Zagrijtschuk, Oleh; Castro, Henry; Bose, Prithviraj

Indirect treatment comparison of momelotinib vs fedratinib safety in patients with myelofibrosis

间接比较莫美替尼与费德拉替尼在骨髓纤维化患者中的安全性

Masarova, Lucia; Verstovsek, Srdan; Palandri, Francesca; Mesa, Ruben; Harrison, Claire; Sajeev, Gautam; Gorsh, Boris; Simpson, Ryan; Cho, Sang; Wang, Zhaohui; Ellis, Catherine; Conlon, Seán; Signorovitch, James

Indirect treatment comparisons of momelotinib vs pacritinib safety and anemia outcomes in patients with myelofibrosis

间接比较莫美替尼与帕克替尼治疗骨髓纤维化患者的安全性和贫血结局

Masarova, Lucia; Verstovsek, Srdan; Palandri, Francesca; Mesa, Ruben; Harrison, Claire; Dobi, Balázs; Gorsh, Boris; Wang, Zhaohui; Ellis, Catherine; Patnaik, Dwaipayan; Liu, Tom; Kapetanakis, Venediktos

Outcomes of patients with acute myeloid leukemia and bone marrow fibrosis

急性髓系白血病和骨髓纤维化患者的预后

Urrutia, Samuel; Kantarjian, Hagop M; Ravandi-Kashani, Farhad; Bueso-Ramos, Carlos; Kanagal-Shamanna, Rashmi; Jabbour, Elias; Montalban-Bravo, Guillermo; Short, Nicholas J; Daver, Naval; Borthakur, Gautam; Dinardo, Courtney D; Kadia, Tapan M; Masarova, Lucia; Bose, Prithviraj; Pemmaraju, Naveen; Garcia-Manero, Guillermo; Sasaki, Koji